BCI Marketplace
Brain-Computer Interface trials

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

RecruitingNCT06094205Phase: NAStarted 2023-10-16

Summary

The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
80 Years

Inclusion Criteria: * Between 18 and 80 years of age * Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders * Complete or incomplete tetraplegia (quadriplegia) * Must live within a three-hour drive of the Study

Locations

University of California, Davis
Sacramento, California, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →